{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T02:55:52Z","timestamp":1792896952858,"version":"4.5.0"},"reference-count":53,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brit J Clinical Pharma"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:sec><jats:title>Aims<\/jats:title><jats:p>The objective was to compare major bleeding risk of direct oral anticoagulants (DOACs; per type and dose) with vitamin K antagonists (VKAs), irrespective of indication, using real\u2010world data.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A population\u2010based prospective cohort study, using the French national health data system (SNIIRAM), identified 47 469 adults living within 5 well\u2010defined geographical areas, who were new users of oral anticoagulants in the period 2013\u20132015: 20 205 VKA users, 19 579 rivaroxaban users, 4225 dabigatran users and 3460 apixaban users. From all emergency departments within these areas, clinical data for all adults referred for bleeding was collected and medically validated. The databases were linked for common key variables. The main outcome measure was major bleeding: intracranial haemorrhage, major gastrointestinal bleeding and other major bleeding events. Hazard ratios were derived from adjusted Cox proportional hazard models. We used propensity score weighting as a sensitivity analysis, with separate analyses according to indications (atrial fibrillation or venous thromboembolism).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Compared to VKAs, high and low\u2010dose DOACs were associated with a reduced risk of intracranial haemorrhage (adjusted hazard ratio 0.55, 95% confidence interval 0.37\u20130.82 and 0.54, 0.26\u20131.12 respectively), and a reduced risk of other major bleeding events (0.41, 0.29\u20130.58 and 0.41, 0.22\u20130.79 respectively), irrespective of duration and indication. Neither DOAC dose evidenced any significant difference from VKAs in terms of risk of major gastrointestinal bleeding.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>There is a clear benefit of using DOACs with regard to intracranial haemorrhage. The study provides new insight into major gastrointestinal and other major bleeding events.<\/jats:p><\/jats:sec>","DOI":"10.1111\/bcp.14362","type":"journal-article","created":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T09:31:22Z","timestamp":1589621482000},"page":"2519-2529","source":"Crossref","is-referenced-by-count":21,"title":["Major bleeding risk associated with oral anticoagulant in real clinical practice. A multicentre 3\u2010year period population\u2010based prospective cohort study"],"prefix":"10.1111","volume":"86","author":[{"given":"Jacques","family":"Bouget","sequence":"first","affiliation":[{"name":"Univ Rennes, CHU Rennes, EA 7449 [Pharmacoepidemiology and Health Services Research] REPERES  Rennes France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Balusson","sequence":"additional","affiliation":[{"name":"Univ Rennes, CHU Rennes, EA 7449 [Pharmacoepidemiology and Health Services Research] REPERES  Rennes France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Maignan","sequence":"additional","affiliation":[{"name":"Emergency Department University Hospital  Grenoble France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laure","family":"Pavageau","sequence":"additional","affiliation":[{"name":"Emergency Department University hospital  Nantes France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre\u2010Marie","family":"Roy","sequence":"additional","affiliation":[{"name":"Emergency Department University hospital  Angers France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karine","family":"Lacut","sequence":"additional","affiliation":[{"name":"CIC 1412, Universit\u00e9 de Bretagne Loire, Universit\u00e9 de Brest, INSERM, CHRU de Brest  Brest France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7047-9107","authenticated-orcid":false,"given":"Lucie\u2010Marie","family":"Scailteux","sequence":"additional","affiliation":[{"name":"Univ Rennes, CHU Rennes, EA 7449 [Pharmacoepidemiology and Health Services Research] REPERES  Rennes France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Nowak","sequence":"additional","affiliation":[{"name":"CIC 1412, Universit\u00e9 de Bretagne Loire, Universit\u00e9 de Brest, INSERM, CHRU de Brest  Brest France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9837-2977","authenticated-orcid":false,"given":"Emmanuel","family":"Oger","sequence":"additional","affiliation":[{"name":"Univ Rennes, CHU Rennes, EA 7449 [Pharmacoepidemiology and Health Services Research] REPERES  Rennes France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,6]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.11-2292"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsa1103053"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2013.10.024"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1009638"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0905561"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1107039"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.03.020"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2014.01.031"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1160\/TH15-03-0247"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jjcc.2016.08.010"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.115.011476"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.114.012061"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1093\/ehjcvp\/pvw031"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2015.11.067"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1160\/TH15-06-0497"},{"issue":"12","key":"e_1_2_11_17_1","first-page":"907","article-title":"Ischaemic and haemorrhagic stroke associated with non\u2010vitamin k antagonist oral anticoagulants and warfarin use in patients with atrial fibrillation: a nationwide cohort study","volume":"38","author":"Staerk L","year":"2017","journal-title":"Eur Heart J"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.1160\/TH15-06-0453"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.116.003725"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.06.062"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2016.1237937"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2014.07.024"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2014.907140"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h1857"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2014.5398"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h1585"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.115.001798"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.12863"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.1160\/TH16-03-0203"},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2016.1161610"},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.117.017549"},{"key":"e_1_2_11_32_1","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.117.018395"},{"key":"e_1_2_11_33_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k2505"},{"key":"e_1_2_11_34_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-019-0841-6"},{"key":"e_1_2_11_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/fcp.12444"},{"key":"e_1_2_11_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/jth.13140"},{"key":"e_1_2_11_37_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.10-0134"},{"key":"e_1_2_11_38_1","doi-asserted-by":"publisher","DOI":"10.1097\/MLR.0000000000000471"},{"key":"e_1_2_11_39_1","doi-asserted-by":"publisher","DOI":"10.1080\/00273171.2011.568786"},{"key":"e_1_2_11_40_1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwn164"},{"key":"e_1_2_11_41_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.319.7223.1492"},{"key":"e_1_2_11_42_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.115.015710"},{"key":"e_1_2_11_43_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.4580"},{"key":"e_1_2_11_44_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i3189"},{"key":"e_1_2_11_45_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j510"},{"key":"e_1_2_11_46_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12911"},{"key":"e_1_2_11_47_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13412"},{"key":"e_1_2_11_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2015.01.159"},{"key":"e_1_2_11_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2017.04.031"},{"key":"e_1_2_11_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)62343-0"},{"key":"e_1_2_11_51_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2016.5954"},{"key":"e_1_2_11_52_1","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2017.39"},{"key":"e_1_2_11_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2016.11.117"},{"key":"e_1_2_11_54_1","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2017.1345729"}],"container-title":["British Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbcp.14362","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bcp.14362","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/bcp.14362","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bcp.14362","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T06:12:17Z","timestamp":1693807937000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/bcp.14362"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":53,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["10.1111\/bcp.14362"],"URL":"https:\/\/doi.org\/10.1111\/bcp.14362","archive":["Portico"],"relation":{},"ISSN":["0306-5251","1365-2125"],"issn-type":[{"value":"0306-5251","type":"print"},{"value":"1365-2125","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6]]}}}